Biomerica, Inc.

Rentabilité sur six mois: +512.32%
Rendement en dividendes: 0%
Secteur: Healthcare

3.2 $

0 $ 0%
0.266 $
3.88 $

paper.min_max_per_year

Calendrier des promotions Biomerica, Inc.

À propos de l'entreprise Biomerica, Inc.

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; Helicobacter pylori test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Paramètres de base

IPO date
2005-01-03
ISIN
US09061H3075
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 1.94 7
P/BV 1.6 8
P/E 0 0
Efficacité
Nom Signification Grade
ROA -50.43 0
ROE -65.28 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.131 10
Debt/Ratio 0.0848 10
Debt/Equity 0.404 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % -19.18 0
Rentabilité Ebitda, % 215.42 10
Rentabilité EPS, % 54.44 7

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 3.2 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 3.43 $ 0 $ 0 $ -6.71 % 0 % 0 %
common.calendar.number_days.30d 3.11 $ 3.2 $ 3.43 $ 2.89 % 0 % 0 %
common.calendar.number_days.90d 0.535 $ 0.4201 $ 3.88 $ 498.13 % 0 % 0 %
common.calendar.number_days.180d 0.5226 $ 0.3211 $ 3.88 $ 512.32 % 0 % 0 %
common.calendar.number_days.1y 0.46 $ 0.266 $ 3.88 $ 595.65 % 0 % 0 %
common.calendar.number_days.3y 3.39 $ 0.266 $ 4.17 $ -5.6 % 0 % 0 %
common.calendar.number_days.5y 8.98 $ 0.266 $ 12.04 $ -64.37 % 0 % 0 %
common.calendar.number_days.10y 0.266 $ 0.266 $ 16 $ 1203.01 % 0 % 0 %
common.calendar.number_days.ytd 0.4705 $ 0.303 $ 3.88 $ 580.13 % 0 % 0 %

Principaux propriétaires

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Gary Lu CPA Principal Accounting Officer & CFO 260k 1981 (44 année)
Ms. Lucy Liu Ph.D. Director of Manufacturing & Technical Operations N/A
Mr. Robert W. Carlson Chief Commercial Officer N/A
Mr. Zackary S. Irani CEO & Director 1966 (59 années)
Mr. Allen C. Barbieri Executive Vice-Chairman of the Board & Corporate Secretary 1958 (67 années)

Informations sur l'entreprise

Adresse: United States, Irvine. CA, 17571 Von Karman Avenue - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.biomerica.com